Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study

scientific article published in September 2011

Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00213-011-2454-6
P698PubMed publication ID21881874
P5875ResearchGate publication ID51609641

P2093author name stringRu-Band Lu
I Hui Lee
Sheng-Yu Lee
Tzung Lieh Yeh
Yen Kuang Yang
Po See Chen
Mei-Hsiu Liao
Kao Chin Chen
Nan-Tsing Chiu
Shih-Hsien Lin
Wei Jen Yao
P2860cites workDual dopamine/serotonin releasers: potential treatment agents for stimulant addictionQ24641896
From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcoticsQ24648063
Dopamine type 2/3 receptor availability in the striatum and social status in human volunteersQ24656174
Cellular and molecular mechanisms of drug dependenceQ28283898
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10Q29547745
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving ratsQ29619737
Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine rewardQ30480008
The economic costs of heroin addiction in the United StatesQ31799483
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.Q32068809
Genetic determinants of addiction to opioids and cocaineQ33222411
Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine.Q33692842
Correlation between errors on the Wisconsin Card Sorting Test and the availability of striatal dopamine transporters in healthy volunteersQ33712203
Dopamine receptor partial agonists could address the duality of cocaine cravingQ33818914
Clinical Efficacy of Citalopram Alone or Augmented with Bupropion in Methadone-Stabilized PatientsQ58298745
The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant cravingQ34043735
Subtypes of nonmedical opioid users: results from the national epidemiologic survey on alcohol and related conditionsQ34258698
Dopamine and serotonin transporter availability in chronic heroin users: a [¹²³I]β-CIT SPECT imaging studyQ34447503
Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion.Q35014407
The dopamine hypothesis of drug addiction: hypodopaminergic state.Q36083476
Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuseQ36905256
Imaging dopamine's role in drug abuse and addictionQ37212526
Relationship between psychostimulant-induced "high" and dopamine transporter occupancyQ37339845
Is correction for age necessary in neuroimaging studies of the central serotonin transporter?Q40609777
New methods for registering long-time I-123 ADAM SPECT image sequences to magnetic resonance imagesQ43053488
Relevance of perceived childhood neglect, 5-HTT gene variants and hypothalamus-pituitary-adrenal axis dysregulation to substance abuse susceptibility.Q43262748
A 33-year follow-up of narcotics addictsQ43464719
Striatal dopaminergic and serotonergic markers in human heroin usersQ43562234
Modulations of spinal serotonin activity affect the development of morphine toleranceQ43619346
Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulationQ44336542
Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT.Q44748980
Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease.Q44762719
Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populationsQ44927023
Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophreniaQ45090583
Serotonin transporter promoter polymorphism genotype is associated with temperament, personality traits and illegal drugs use among adolescents.Q45235253
Social support and striatal dopaminergic activities: is there a connection?Q45961376
Accumbal dopamine and serotonin activity throughout acquisition and expression of place conditioning: correlative relationships with preference and aversionQ46107939
Association analysis of polymorphisms in serotonin 1B receptor (HTR1B) gene with heroin addiction: a comparison of molecular and statistically estimated haplotypesQ46350764
Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphineQ46425229
Correlation between different memory systems and striatal dopamine D2/D3 receptor density: a single photon emission computed tomography studyQ46446715
123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary studyQ46529213
Neuroimaging studies of brain corpus striatum changes among heroin-dependent patients treated with herbal medicine, U'finer capsuleQ46658100
Greater availability of dopamine transporters in patients with major depression--a dual-isotope SPECT studyQ46737222
The serotonin/noradrenaline reuptake inhibitor venlafaxine attenuates acquisition, but not maintenance, of intravenous self-administration of heroin in ratsQ46834102
The correlation between striatal dopamine D2/D3 receptor availability and verbal intelligence quotient in healthy volunteersQ46855065
Lower serotonin transporter binding potential in the human brain during major depressive episodesQ46877839
PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin usersQ46918892
Decreased dopamine transporter availability in male smokers -- a dual isotope SPECT studyQ46977708
Development of the Taiwanese Depression QuestionnaireQ47640616
Reduction in dopamine transporter mRNA after cessation of repeated cocaine administrationQ48167688
Association between serotonin transporter availability and hostility scores in healthy volunteers - a single photon emission computed tomography study with [(123)I] ADAM.Q48248698
Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imagingQ48278681
Changes of dopamine transporter function in striatum during acute morphine addiction and its abstinence in rhesus monkeyQ48374107
Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine cravingQ48421523
Alteration in regulation of serotonin release in rat dorsal raphe nucleus after prolonged exposure to morphine.Q48434351
PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeysQ48475729
Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction.Q48496653
Midbrain binding of [123I]nor-beta-CIT in atypical depressionQ48564635
Morphine Tolerance, Physical Dependence, and Synthesis of Brain 5-HydroxytryptamineQ49118851
Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine.Q51545783
Effects of venlafaxine and desipramine on heroin-induced conditioned place preference in the rat.Q52015761
P433issue1
P921main subjectserotoninQ167934
opioidQ427523
P304page(s)55-64
P577publication date2011-09-01
P1433published inPsychopharmacologyQ1422802
P1476titleAvailability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study
P478volume220

Reverse relations

cites work (P2860)
Q34100243An-jun-ning, a traditional herbal formula, attenuates spontaneous withdrawal symptoms via modulation of the dopamine system in morphine-dependent rats
Q37474677Association between serotonin transporter gene polymorphisms and heroin dependence: a meta-analytic study
Q44252390Dopamine transporter availability in heroin-dependent subjects and controls: longitudinal changes during abstinence and the effects of Jitai tablets treatment
Q35781879Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients
Q47442146Effects of Jitai tablet, a traditional Chinese medicine, on spontaneous withdrawal symptoms and modulation of dopaminergic functions in morphine-dependent rats
Q59791239Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies
Q47681730Longitudinal changes of dopamine transporters in heroin users during abstinence
Q48244859Pharmacogenetic analysis of opioid dependence treatment dose and dropout rate.
Q50634606Positive association between neuroticism and working memory in healthy female volunteers.
Q50129912Prefrontal cortex modulates the correlations between brain-derived neurotrophic factor level, serotonin, and the autonomic nervous system
Q35910290Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders
Q44348330Reduced striatal dopamine transporter density associated with working memory deficits in opioid-dependent male subjects: a SPECT study
Q34942640Serotonin and mental disorders: a concise review on molecular neuroimaging evidence
Q33841496The relationship between the dopaminergic system and depressive symptoms in cervical dystonia

Search more.